In This Article
What These Peptides Actually Are
To understand this combination, you need to understand how your body naturally produces growth hormone. It's a two-signal system:
- Signal 1: GHRH (Growth Hormone Releasing Hormone) - your hypothalamus releases this to tell your pituitary gland "make growth hormone now"
- Signal 2: Ghrelin - the "hunger hormone" also triggers GH release through a completely different receptor (the GHSR receptor)
CJC-1295 mimics Signal 1. Ipamorelin mimics Signal 2. Together, they hit both switches at the same time.
CJC-1295
CJC-1295 is a modified version of GHRH (growth hormone releasing hormone). The natural version of GHRH is broken down by your body in minutes. CJC-1295 has been modified to last much longer - it binds to albumin in your blood (the DAC version) or has a modified amino acid sequence (modified GRF 1-29, often called "CJC-1295 without DAC"). This means instead of a brief spike in GH, you get a sustained elevation that lasts hours to days.
Ipamorelin
Ipamorelin is a synthetic version of ghrelin - but a very selective one. This is its key advantage. Natural ghrelin increases growth hormone, but it also increases cortisol (stress hormone) and prolactin. Ipamorelin triggers GH release without touching cortisol or prolactin. This selectivity is what makes it stand out from older secretagogues like GHRP-6 or GHRP-2, which had more side effects because they hit multiple hormone pathways.
What The Combination Does
- Increases growth hormone 3-8x above baseline - published models consistently show this elevation range when both peptides are used together
- Maintains natural GH pulsatility - unlike injecting synthetic growth hormone (which flatlines your natural production), these peptides work through your own pituitary. Your body still controls the pulses - they're just amplified
- Increases IGF-1 - sustained CJC-1295 administration showed dose-dependent increases in IGF-1 levels that lasted 6-8 days after a single injection in healthy adults
- No cortisol or prolactin increase - ipamorelin's selectivity means you don't get the stress hormone spikes that older GH peptides caused
- Preserves the GH feedback loop - somatostatin (the "off switch" for GH) still works normally, preventing excess GH levels. This is a fundamental safety advantage over synthetic GH injection
What The Human Research Shows
The CJC-1295 Trial (2006)
A clinical study in healthy adults aged 21-61 showed that subcutaneous CJC-1295 produced sustained, dose-dependent increases in both GH and IGF-1. At doses of 30 and 60 mcg/kg, it was well tolerated. IGF-1 levels increased by 36-69% and remained elevated for up to 28 days after a single injection. This was a proper pharmacokinetic study - measuring what the drug does in the body - and the results were clear.
What We Don't Have
Here's the gap: there are no published, peer-reviewed clinical trials demonstrating that this combination actually delivers the outcomes people use it for - better body composition, improved recovery, anti-ageing effects. The pharmacokinetic data is solid (it raises GH and IGF-1). The outcome data (does that translate to meaningful clinical benefits in healthy adults?) doesn't exist in proper trials.
We know GH and IGF-1 are involved in muscle repair, fat metabolism, bone density, skin quality, and sleep architecture. We know these peptides reliably raise those hormones. What's missing is the controlled evidence connecting those elevated levels to real-world results in healthy people using these specific compounds.
Who Uses It And Why
- Anti-ageing clinics - this is the most prescribed peptide combination in longevity medicine. The rationale: GH production declines roughly 14% per decade after 30. Restoring more youthful GH levels may slow aspects of ageing
- Athletes and bodybuilders - for recovery, fat loss, and muscle growth. The advantage over synthetic GH: lower cost, arguably safer (maintains feedback loops), and harder to detect in drug testing
- Post-injury recovery - GH accelerates tissue repair. Some practitioners prescribe this combination during rehabilitation
- Sleep optimisation - GH is released primarily during deep sleep. Users consistently report improved sleep quality, though this hasn't been formally studied with this combination
Dosing - What Clinics Typically Use
- CJC-1295 (without DAC / mod GRF 1-29): 100-300mcg subcutaneously, typically before bed
- Ipamorelin: 100-300mcg subcutaneously, same injection timing
- Frequency: 5 days on, 2 days off - or daily before bed
- Cycle length: typically 8-12 weeks, followed by a break
- Timing matters: taken on an empty stomach, at least 2 hours after eating. Food (especially carbohydrates and fats) blunts GH release
Side Effects To Know About
- Water retention - the most common complaint. GH causes sodium retention, which means temporary bloating and puffiness, especially in hands and face
- Tingling and numbness - carpal tunnel-like symptoms from GH-related fluid changes. Usually resolves with dose reduction
- Increased hunger - ipamorelin still has mild ghrelin-like appetite effects in some users
- Joint stiffness - from fluid changes. Typically resolves over a few weeks
- Vivid dreams - commonly reported. Likely related to increased deep sleep phases
The Honest Bottom Line
CJC-1295 and ipamorelin reliably raise growth hormone and IGF-1 levels - the pharmacokinetic evidence is clear. What's missing is the controlled clinical evidence that this translates into the specific outcomes people are paying for (better body composition, anti-ageing, recovery). The biological rationale is sound, the mechanism is well-understood, and the safety profile appears favourable compared to synthetic GH. But "should raise GH safely" and "proven to deliver results" are different claims. Know which one you're acting on.
For the full peptide landscape, read the Complete Peptide Guide.
This article is for educational purposes only. It is not medical advice. Peptides discussed here may not be approved for human use in your country. Always consult a qualified medical professional before making any health decisions.